Sayali Dighe

Nagar, PB 160062, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Exploring Synergistic Potential of Sorafenib and Atorvastatin to Launch Apoptosis and Ferroptosis-driven Mixed Cell Death Mechanism in Colorectal Cancer.

Exploring Synergistic Potential of Sorafenib and Atorvastatin to Launch Apoptosis and Ferroptosis-driven Mixed Cell Death Mechanism in Colorectal Cancer.

Journal: AAPS PharmSciTech

Published: April 01, 2026

Targeted phenylboronic acid-rosuvastatin based nanoconstructs: A novel therapeutic avenue for treatment of colorectal cancer.

Targeted phenylboronic acid-rosuvastatin based nanoconstructs: A novel therapeutic avenue for treatment of colorectal cancer.

Journal: Nanomedicine : nanotechnology, biology, and medicine

Published: March 26, 2026

Investigating the Potential of High Permeation Vesicle-Based Methotrexate Gel for Localized Therapy in Rheumatoid Arthritis.

Investigating the Potential of High Permeation Vesicle-Based Methotrexate Gel for Localized Therapy in Rheumatoid Arthritis.

Journal: Pharmaceutical research

Published: September 18, 2025

Nanotherapeutics-induced pyroptosis for targeted cancer therapy: mechanistic insights and translational prospects.

Nanotherapeutics-induced pyroptosis for targeted cancer therapy: mechanistic insights and translational prospects.

Journal: Drug discovery today

Published: August 05, 2025

Nutrient-transporter driven cytotoxic potential: an emerging nanotherapeutic approach.

Nutrient-transporter driven cytotoxic potential: an emerging nanotherapeutic approach.

Journal: Drug discovery today

Published: March 15, 2025

Dual acting oxaliplatin (IV) prodrug loaded albumin nanoparticles for safer synergistic anticancer action against triple negative breast cancer.

Dual acting oxaliplatin (IV) prodrug loaded albumin nanoparticles for safer synergistic anticancer action against triple negative breast cancer.

Journal: Drug delivery and translational research

Published: February 26, 2025

Co-Delivery of Glycyrrhizin and Paclitaxel via Gelatin-Based Core-Shell Nanoparticles Ameliorates 1,2-Dimethylhydrazine-Induced Precancerous Lesions in Colon.

Co-Delivery of Glycyrrhizin and Paclitaxel via Gelatin-Based Core-Shell Nanoparticles Ameliorates 1,2-Dimethylhydrazine-Induced Precancerous Lesions in Colon.

Journal: ACS biomaterials science & engineering

Published: January 27, 2025

Crosslinked hydroxypropyl-β-cyclodextrin nanoparticles for improved efficacy of venetoclax against triple negative breast cancer.

Crosslinked hydroxypropyl-β-cyclodextrin nanoparticles for improved efficacy of venetoclax against triple negative breast cancer.

Journal: International journal of pharmaceutics

Published: November 23, 2024

Bifunctional Oxaliplatin (IV) Prodrug Based pH-Sensitive PEGylated Liposomes for Synergistic Anticancer Action Against Triple Negative Breast cancer.

Bifunctional Oxaliplatin (IV) Prodrug Based pH-Sensitive PEGylated Liposomes for Synergistic Anticancer Action Against Triple Negative Breast cancer.

Journal: AAPS PharmSciTech

Published: September 12, 2024

Unveiling the potential of ursolic acid modified hyaluronate nanoparticles for combination drug therapy in triple negative breast cancer.

Unveiling the potential of ursolic acid modified hyaluronate nanoparticles for combination drug therapy in triple negative breast cancer.

Journal: Carbohydrate polymers

Published: March 06, 2024

Harnessing the potential of fatty Acid-Surfactant-Based micellar gel for enhanced topical delivery of Apremilast in psoriasis treatment.

Harnessing the potential of fatty Acid-Surfactant-Based micellar gel for enhanced topical delivery of Apremilast in psoriasis treatment.

Journal: International journal of pharmaceutics

Published: December 14, 2023

Showing 1-11 of 11

Last Updated: 09/26/2026